Evidence map›Paper›PMID 36574984›Full record

ArticleBMJ open2022

Sarcopenia and coexistent risk factors detected using the 'Yubi-wakka' (finger-ring) test in adults aged over 65 years in the public annual health check-up in Tama City, Tokyo: a cross-sectional study.

Hitomi Fujii, Eitaro Kodani, Tomohiro Kaneko, Hiroyuki Nakamura, Hajime Sasabe, Yutaka Tamura

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Patients' Perceptions of Biosimilars: A Systematic Review.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hitomi FujiiInternal Medicine, Tama Center Mirai Clinic, Tama, Japan hitomif@tama-mirai.com.ORCID 0000-0003-4831-9320
Eitaro KodaniDepartment of Cardiovascular Medicine, Nippon Medical School Tama Nagayama Hospital, Tama, Japan.ORCID 0000-0002-4271-3186
Tomohiro KanekoDepartment of Nephrology, Nippon Medical School Tama Nagayama Hospital, Tama, Japan.
Hiroyuki NakamuraTama City Medical Association, Tama, Japan.
Hajime SasabeTama City Medical Association, Tama, Japan.
Yutaka TamuraTama City Medical Association, Tama, Japan.
Tokyo Metropolitan Tama Medical Center · JPNippon Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine the positive rate of sarcopenia using the 'Yubi-wakka' (finger-ring) test and associated risk factors among adults aged 65 years and older.

designCross-sectional study.

settingWe used the Yubi-wakka test, which has been developed and validated as a predictor of sarcopenia, frailty, disability and mortality. A positive test result is indicated by a smaller calf circumference than the finger-ring. The test was administered during annual health check-ups among residents of Tama City, Japan.

participantsDuring the 2019 fiscal year, 12 894 individuals aged 65 years and older underwent the Yubi-wakka test at primary care clinics.

interventionsExaminees conducted the test themselves in a seated position. They formed a ring around their calf using both thumbs and index fingers and judged whether their calf was larger, the same or smaller than their finger-ring. PRIMARY AND SECONDARY OUTCOME MEASURES: We compared anthropometric and serological data between the positive (smaller calf) and negative (larger calf) test result groups.

resultsThe positive rate was 15.4% among men and 18.5% among women. The prevalence of a positive result was higher in those aged ≥80 years than in younger age groups in both sexes (men: 22.8%; women: 28.8%). Multivariate logistic regression analysis showed that a diagnosis of metabolic syndrome was a risk factor for detecting a positive test result in women aged 65-74 years (OR 3.445; 95% CI 1.44 to 8.29) and ≥75 years (OR 3.37; 95% CI 1.97 to 5.78).

conclusionsBecause the Japanese population is healthy and lives long, interventions against sarcopenia are important, especially for older adults aged >75 years. The presence of metabolic syndrome may be a risk factor for sarcopenia (as detected by the Yubi-wakka test) and future frailty, and requires closer attention, especially among women.

Indexed as

FrailtyMetabolic SyndromeSarcopeniaAgedCross-Sectional StudiesFemaleGeriatric AssessmentHumansMaleRisk FactorsTokyoGERIATRIC MEDICINEHEALTH SERVICES ADMINISTRATION & MANAGEMENTMusculoskeletal disordersPRIMARY CAREPUBLIC HEALTH

Identifiers

PMID36574984
PMCPMC9806034
OpenAlexW4313250922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.